Organicell

Organicell (BPSR) a Triple Since Easter.

Slowly she turns, step-by-step. $20 million gain in market value. Spurred by FDA Emergency IND's. RELATED: Adding Organicell (BPSR)...

After FDA authorizes at-home saliva test for Covid-19, startups begin selling test kits.

MedCityNews The FDA gave an emergency use authorization for the first saliva-based Covid-19 test developed by RUCDR Infinite Biologics....
Biotech Stock Review

Biotech Stock Review Adds One Medical (ONEM) $28.50 to Watchlist.

It Ain't Cheap at $3.5 Billion.It's Near Doubled Since March 20th.But Look at the Growth.Look at the Cash.Don't Look at the Bottom...
Mitesco Inc,. Biotech Stock Review

Biotech Stock Review: Mitesco (MITI) $0.03, Report Update

Mitesco to Launch Telehealth Enabled Primary Care Clinic Business with Q4 Rollout Addressing Healthcare Backlog Accentuated by the Second Wave Concerns.

Update: Biotech 5 Pack. 5 Biotech Stocks, we Expected to Double in 2020.

No Doubles Yet, But They're Doing Rather Well, Considering Everything. Our Confidence Remains Unwavered. Best Performer up 63%.

Citius Pharma (CTXR) Seeks Expeditious Pathway Into the Clinic, for CoronaVirus Related Acute Respiratory...

Sumbmits pre-IND Into Coronavirus Treatment Acceleration Program (CTAP).   Citius Announces Pre-IND Submission to FDA Under the Coronavirus...
Immunomedics IMMU, Biotech Stock Review

Immunomedics (IMMU) up 100% Today or $2 Billion in Value.

Again as mentioned a few weeks ago, our bearish market opinion is related to large-caps and large-cap funds and ETF's. If...

European Hand Sanitizer Market Expected to Reach $9.4 Billion by 2027.

Growing at a CAGR of 38.4% during 2019–2027. The European hand sanitizer market was valued at US$ 641.7 million...
Super Gonorrhea

Antibiotic-Resistant Super Gonorrhea (CDC).

"We are currently down to one last recommended and effective class of antibiotics, cephalosporins, to treat this common...

CDC’s Worst-Case Coronavirus Model: 214 Million Infected, 1.7 Million Dead (Intelligencer)

A recent CDC projection estimated that the U.S. coronavirus epidemic could infect between 160 million and 214 million people over a period...

Latest article

Nine Page Summary Report on GeoVax (GOVX)

This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

Award of BARDA Project NextGen contract represents a significant milestone event; Total value...